Login

President Satoshi Ogiso: Leading the Way Forward | Satoshi Ogiso - President & CEO of Hino Motors 00:10:00

Share On Facebook Share On Twitter

Satoshi Ogiso is President/CEO/Chro at Hino Motors Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
veon CEO Kaan Terzioğlu believes that emerging markets can be more progressive and forward-looking.
00:10:00
Thunderful Group Strengthens Portfolio with Acquisition of Early Morning Studio | Brjann Sigurgeirsson, CEO, Thunderful Group AB.
00:10:00
Thomas Ruggia, President & CEO of Samsara Vision.
00:10:00
Navigating Alternative Investments: Insights from Stephan Engelbrecht of Capricorn Fund Managers | Stephan Engelbrecht - Fund Manager, Capricorn Sanlam Collective Investments Hedge Fund
00:10:00
Friskin Mines: Navigating Bureaucracy and Unlocking Potential in France's Mining Sector
00:10:00
South Africa's History: From Boer Wars to Present Geopolitics|Thula Simpson,Professor,University of Pretoria
00:10:00
Peter Thiels AI Investment Strategy|Peter Thiel,Managing Partner,Founders Fund
00:10:00
Powering Independence: The Rise of Off-Grid and Decentralized Energy in the Nordics | Lars Eriksson - Energy Systems Specialist, Nordic Energy Research
00:10:00
AI Integration and SPAC Merger: Cellularity CEO Discusses Advances in Cancer Treatment and Lessons from the Pandemic| Robert Hariri, M.D., Ph.D., CEO, Celularity Inc.
00:10:00
Shaping Global Portfolios: Key Trends Influencing Offshore Investment Strategies
00:10:00
Understanding the Impact: A Deep Dive into Blockchain Applications in Real Estate | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
A 2012 Master of Financial Engineering graduate is now a Senior Vice President at Cerberus Capital Management in New York City.|Mr. Feinberg is Co-Founder, Co-Chief Executive Officer, and Chief Investment Officer of Cerberus

© 2017 - Neuhu+